(Q62110125)
Statements
Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma Whose Disease Has Been Controlled With Chemotherapy: Rituximab Anti-CD20 Monoclonal Antibody or Interferon Alpha 2-b as Maintenance Therapy (English)
0 references
June 1998
0 references
June 1999
0 references
0
0 references